Researcher Profile

Researcher Profile

Diane Hershock, MD, PhD

Diane Hershock, MD, PhD

Associate Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
Disease Teams:
Head and Neck Cancer
Melanoma and Skin Cancer
dmh58@psu.edu

Research Interests

  • Radiotherapy
  • Therapeutics
  • Blood Platelets
  • Head and Neck Neoplasms
  • Neoplasms
  • Drug Therapy
  • Fibrinogen
  • Survival
  • Squamous Cell Carcinoma of Head and Neck
  • Organ Preservation
  • Radiation Oncology
  • Chymotrypsin

Clinical Trials

Exercise in All ChemoTherapy (EnACT)
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma
A Phase Ib/11 Study of Propranolol with fixed-dose Pembrolizumab in Patients with Unresectable Stage III and Stage IV Melanoma
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial
The PISCES Study: A Multicenter Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid (tavo, pIL-12) plus Electroporation in Combination with Intravenous Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressing on either Pembrolizumab or Nivolumab Treatment

Recent Publications

2020

Lewcun, JA, Pameijer, C, Kass, R, Cream, L, Hershock, D, Brooks, AJ & Dodge, DG 2020, 'Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports', International Journal of Surgery Case Reports, vol. 68, pp. 83-87. https://doi.org/10.1016/j.ijscr.2020.02.036

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)